| Probiotics improve gut microbiota dysbiosis in obese mice fed a high-fat or high-sucrose diet C Kong, R Gao, X Yan, L Huang, H Qin Nutrition 60, 175-184, 2019 | 436 | 2019 |
| Ketogenic diet for human diseases: the underlying mechanisms and potential for clinical implementations H Zhu, D Bi, Y Zhang, C Kong, J Du, X Wu, Q Wei, H Qin Signal transduction and targeted therapy 7 (1), 11, 2022 | 295 | 2022 |
| Dysbiosis signatures of gut microbiota along the sequence from healthy, young patients to those with overweight and obesity R Gao, C Zhu, H Li, M Yin, C Pan, L Huang, C Kong, X Wang, Y Zhang, ... Obesity 26 (2), 351-361, 2018 | 228 | 2018 |
| Dysbiosis of human gut microbiome in young-onset colorectal cancer Y Yang, L Du, D Shi, C Kong, J Liu, G Liu, X Li, Y Ma Nature communications 12 (1), 6757, 2021 | 178 | 2021 |
| Ketogenic diet alleviates colitis by reduction of colonic group 3 innate lymphoid cells through altering gut microbiome C Kong, X Yan, Y Liu, L Huang, Y Zhu, J He, R Gao, MF Kalady, A Goel, ... Signal transduction and targeted therapy 6 (1), 154, 2021 | 152 | 2021 |
| Dysbiosis signature of mycobiota in colon polyp and colorectal cancer R Gao, C Kong, H Li, L Huang, X Qu, N Qin, H Qin European Journal of Clinical Microbiology & Infectious Diseases 36, 2457-2468, 2017 | 131 | 2017 |
| Mucosa-associated microbiota signature in colorectal cancer R Gao, C Kong, L Huang, H Li, X Qu, Z Liu, P Lan, J Wang, H Qin European journal of clinical microbiology & infectious diseases 36 (11 …, 2017 | 129 | 2017 |
| Integrated metagenomic and metabolomic analysis reveals distinct gut-microbiome-derived phenotypes in early-onset colorectal cancer C Kong, L Liang, G Liu, L Du, Y Yang, J Liu, D Shi, X Li, Y Ma Gut 72 (6), 1129-1142, 2023 | 125 | 2023 |
| Fusobacterium Nucleatum Promotes the Development of Colorectal Cancer by Activating a Cytochrome P450/Epoxyoctadecenoic Acid Axis via TLR4/Keap1/NRF2 … C Kong, X Yan, Y Zhu, H Zhu, Y Luo, P Liu, S Ferrandon, MF Kalady, ... Cancer Research 81 (17), 4485-4498, 2021 | 112 | 2021 |
| The association of post-stroke cognitive impairment and gut microbiota and its corresponding metabolites Y Liu, C Kong, L Gong, X Zhang, Y Zhu, H Wang, X Qu, R Gao, F Yin, ... Journal of Alzheimer's Disease 73 (4), 1455-1466, 2020 | 88 | 2020 |
| Human oral microbiome dysbiosis as a novel non-invasive biomarker in detection of colorectal cancer S Zhang, C Kong, Y Yang, S Cai, X Li, G Cai, Y Ma Theranostics 10 (25), 11595, 2020 | 77 | 2020 |
| Alterations in intestinal microbiota of colorectal cancer patients receiving radical surgery combined with adjuvant CapeOx therapy C Kong, R Gao, X Yan, L Huang, J He, H Li, J You, H Qin Science China Life Sciences 62, 1178-1193, 2019 | 61 | 2019 |
| Integrated analysis of colorectal cancer reveals cross-cohort gut microbial signatures and associated serum metabolites R Gao, C Wu, Y Zhu, C Kong, Y Zhu, Y Gao, X Zhang, R Yang, H Zhong, ... Gastroenterology 163 (4), 1024-1037. e9, 2022 | 58 | 2022 |
| Antibiotic administration shortly before or after immunotherapy initiation is correlated with poor prognosis in solid cancer patients: An up-to-date systematic review and meta … M Yang, Y Wang, M Yuan, M Tao, C Kong, H Li, J Tong, H Zhu, X Yan International immunopharmacology 88, 106876, 2020 | 54 | 2020 |
| Alterations, interactions, and diagnostic potential of gut bacteria and viruses in colorectal cancer R Gao, Y Zhu, C Kong, K Xia, H Li, Y Zhu, X Zhang, Y Liu, H Zhong, ... Frontiers in cellular and infection microbiology 11, 657867, 2021 | 52 | 2021 |
| c‐Myb promotes growth and metastasis of colorectal cancer through c‐fos‐induced epithelial‐mesenchymal transition X Qu, X Yan, C Kong, Y Zhu, H Li, D Pan, X Zhang, Y Liu, F Yin, H Qin Cancer science 110 (10), 3183-3196, 2019 | 38 | 2019 |
| High fat diet exacerbates intestinal barrier dysfunction and changes gut microbiota in intestinal-specific ACF7 knockout mice C Shi, H Li, X Qu, L Huang, C Kong, H Qin, Z Sun, X Yan Biomedicine & Pharmacotherapy 110, 537-545, 2019 | 38 | 2019 |
| Analysis of fecal microbiota in patients with functional constipation undergoing treatment with synbiotics LS Huang, C Kong, RY Gao, X Yan, HJ Yu, B Wen, Q Zhu, TY Shen, ... European Journal of Clinical Microbiology & Infectious Diseases 37, 555-563, 2018 | 38 | 2018 |
| PD-1/PD-L1 pathway and angiogenesis dual recognizable nanoparticles for enhancing chemotherapy of malignant cancer Z Sun, Y Zhang, D Cao, X Wang, X Yan, H Li, L Huang, X Qu, C Kong, ... Drug Delivery 25 (1), 1746-1755, 2018 | 33 | 2018 |
| Application of dual targeting drug delivery system for the improvement of anti-glioma efficacy of doxorubicin Z Sun, X Yan, YB Liu, L Huang, C Kong, X Qu, M Wang, R Gao, H Qin Oncotarget 8 (35), 58823, 2017 | 26 | 2017 |
